Please be advised that ITL’s last day of trading on the ASX will be Friday 8th February 2019
Innovating to
Make Life Easier™
Product Patents
48Countries We Sell To
55Years In Business
25
Essentials for Blood Management and Clinical Procedures
ITL BioMedical enables best clinical outcomes through innovative tools for blood management and clinical procedures. As a global provider of blood management and clinical procedure tools with a significant portfolio of intellectual property, we consistently look to the future and leverage input from healthcare markets worldwide to advance our products. Our world-class manufacturing facility and R&D lab develops and rigorously tests our advancements ensuring our innovations are designed with the utmost quality for introduction on a global basis.
ITL BioMedical enables best clinical outcomes through innovative tools for blood management and clinical procedures. As a global provider of blood management and clinical procedure tools with a significant portfolio of intellectual property, we consistently look to the future and leverage input from healthcare markets worldwide to advance our products. Our world-class manufacturing facility and R&D lab develops and rigorously tests our advancements ensuring our innovations are designed with the utmost quality for introduction on a global basis.
Read More
Direct-to-Consumer Pathology Testing Services
ITL offers MyHealthTest, a highly innovative consumer-based pathology testing service that allows individuals to order tests online or from pharmacies, prepare samples at home and have results delivered electronically.
ITL offers MyHealthTest, a highly innovative consumer-based pathology testing service that allows individuals to order tests online or from pharmacies, prepare samples at home and have results delivered electronically.
Read More
Latest News
- Company to delist from the ASX last trading day 8th February 2019 Read More
- ITL Health Group Limited January 2019 Extraordinary General Meeting Results Read More
- Voluntary Delisting from ASX—ITL Health Group Limited (ASX:ITD) Read More
- ITL Health Group Announces 2017/18 Results Read More
- ITL Health Group Featured on Biotech Daily Read More
